ACTU
Actuate Therapeutics Inc
NASDAQ · Healthcare · Biotechnology · US
$1.48
+8.03%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-2067.8%
Return on equity
-393.4%
Return on assets
-1490.0%
Return on invested capital
0.00x
Asset turnover
-$19.8M
Cash from operations
$0.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026